All Pharma News
price-trendAsk Us
Mallinckrodt Sells Therakos® To CVC For $925 Million

Mallinckrodt Sells Therakos® To CVC For $925 Million
PR NEWSWIRE
06 Aug 2024
Share Share
Mallinckrodt, Terumo BCT announce UVADEX approval in Australia

Mallinckrodt, Terumo BCT announce UVADEX approval in Australia
BIOSPECTRUMASIA
31 Oct 2019
Share Share
Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt pays $1.2bn for Sucampo Pharma
Phil Taylor PMLIVE
03 Jan 2018
Share Share
Mallinckrodt to buy immunotherapy company Therakos for around $1.3 billion

Mallinckrodt to buy immunotherapy company Therakos for around $1.3 billion
Joe Barber FIRST WORD PHARMA
11 Aug 2015
Share Share